but not enough for everyone.” A partial taken from The Conversation on Drug Prices The impact of the drug negotiations has been modest at best. There is a lot of talk and hurrahs. The results are not there yet. When I go to the outside for care, the VA pays the doctors at a minimum. If they want VA patients, them they accept minimal payments. If the VA disappeared those minimal payments would disappear. Like healthcare, pharmaceuticals are...
Read More »Another Administration Win in Medicare Drug Price Negotiation Lawsuits
by Sheela Ranganathan and Zachary Baron Health Affairs Introduction: This article is discussing the efforts of the pharmaceutical companies attempting to block Medicare and the government negotiations with them for pricing. Early on in the District Courts, the pharmaceutical companies are being denied standing. This is why I posted the article. The cases may still go to COA, in particular the 5th COA which has a reputation favoring locals and...
Read More »A New Year in 2022 and New Pharmaceutical pricing, a short Explanation
An early attempt as to explaining the drug market. It is a start and I have to program myself to understand what is said. Brief and down to earth with pictures too! Much of this is a C&P with some editing. Much credit to the authors for giving us this opportunity to understand. Welcoming a New Year with new drug prices, 46brooklyn Research This year has proven to be little different from past years. In keeping with tradition (for as long...
Read More »Rep. Katie Porter on drug prices
Big Pharma says they need to charge astronomical prices to pay for research and development. Yet, the amount they spend on manipulating the market to enrich shareholders completely eclipses what's spent on R&D. Today, I confronted a CEO about the industry's lies, with visuals ⤵️ pic.twitter.com/c3jSLr0yVd— Rep. Katie Porter (@RepKatiePorter) May 18, 2021 Tags: big pharma, drug prices...
Read More »